<?xml version="1.0" encoding="utf-8"?>
<export-example>
  <doc>
    <id>29517</id>
    <completedYear/>
    <publishedYear>2022</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber/>
    <edition/>
    <issue/>
    <volume>10</volume>
    <type>articler</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2022-11-01</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">Vesicle-based cell-free synthesis of short and long unspecific peroxygenases</title>
    <abstract language="eng">Unspecific peroxygenases (UPOs, EC 1.11.2.1) are fungal enzymes that catalyze the oxyfunctionalization of non-activated hydrocarbons, making them valuable biocatalysts. Despite the increasing interest in UPOs that has led to the identification of thousands of putative UPO genes, only a few of these have been successfully expressed and characterized. There is currently no universal expression system in place to explore their full potential. Cell-free protein synthesis has proven to be a sophisticated technique for the synthesis of difficult-to-express proteins. In this work, we aimed to establish an insect-based cell-free protein synthesis (CFPS) platform to produce UPOs. CFPS relies on translationally active cell lysates rather than living cells. The system parameters can thus be directly manipulated without having to account for cell viability, thereby making it highly adaptable. The insect-based lysate contains translocationally active, ER-derived vesicles, called microsomes. These microsomes have been shown to allow efficient translocation of proteins into their lumen, promoting post-translational modifications such as disulfide bridge formation and N-glycosylations. In this study the ability of a redox optimized, vesicle-based, eukaryotic CFPS system to synthesize functional UPOs was explored. The influence of different reaction parameters as well as the influence of translocation on enzyme activity was evaluated for a short UPO from Marasmius rotula and a long UPO from Agrocybe aegerita. The capability of the CFPS system described here was demonstrated by the successful synthesis of a novel UPO from Podospora anserina, thus qualifying CFPS as a promising tool for the identification and evaluation of novel UPOs and variants thereof.</abstract>
    <parentTitle language="eng">Frontiers in Bioengineering and Biotechnology</parentTitle>
    <identifier type="issn">2296-4185</identifier>
    <identifier type="doi">10.3389/fbioe.2022.964396</identifier>
    <enrichment key="opus.import.date">2022-11-17T08:51:13+00:00</enrichment>
    <enrichment key="opus.source">sword</enrichment>
    <enrichment key="opus.import.user">deepgreen</enrichment>
    <enrichment key="opus.import.file">attachment; filename=deposit.zip</enrichment>
    <enrichment key="opus.import.checksum">39a5588d36a6c7d3edd717564dd7e017</enrichment>
    <enrichment key="BTU">an der BTU erstellt / created at BTU</enrichment>
    <enrichment key="Publikationsweg">Open Access</enrichment>
    <enrichment key="Fprofil">2 Gesundheit und Lifes Sciences / Health and Life Sciences</enrichment>
    <author>
      <firstName>Ruben Magnus</firstName>
      <lastName>Walter</lastName>
    </author>
    <author>
      <firstName>Anne</firstName>
      <lastName>Zemella</lastName>
    </author>
    <author>
      <firstName>Marina</firstName>
      <lastName>Schramm</lastName>
    </author>
    <author>
      <firstName>Jan</firstName>
      <lastName>Kiebist</lastName>
    </author>
    <author>
      <firstName>Stefan</firstName>
      <lastName>Kubick</lastName>
    </author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>cell-free protein synthesis</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>enzymes</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>unspecific peroxygenases</value>
    </subject>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>insect cell lysate</value>
    </subject>
    <collection role="institutes" number="2111">FG Enzymtechnologie</collection>
    <collection role="Import" number="import">Import</collection>
  </doc>
  <doc>
    <id>33328</id>
    <completedYear/>
    <publishedYear>2024</publishedYear>
    <thesisYearAccepted/>
    <language>eng</language>
    <pageFirst/>
    <pageLast/>
    <pageNumber>14</pageNumber>
    <edition/>
    <issue/>
    <volume>14</volume>
    <type>articler</type>
    <publisherName/>
    <publisherPlace/>
    <creatingCorporation/>
    <contributingCorporation/>
    <belongsToBibliography>0</belongsToBibliography>
    <completedDate>2024-04-11</completedDate>
    <publishedDate>--</publishedDate>
    <thesisDateAccepted>--</thesisDateAccepted>
    <title language="eng">Synthesis of mono Cytochrome P450 in a modified CHO-CPR cell-free protein production platform</title>
    <abstract language="eng">AbstractCytochromes P450 (CYPs) are a group of monooxygenases that can be found in almost all kinds of organisms. For CYPs to receive electrons from co-substrate NADPH, the activity of NADPH-Cytochrome-P450-oxidoreductase (CPR) is required as well. In humans, CYPs are an integral part of liver-based phase-1 biotransformation, which is essential for the metabolization of multiple xenobiotics and drugs. Consequently, CYPs are important players during drug development and therefore these enzymes are implemented in diverse screening applications. For these applications it is usually advantageous to use mono CYP microsomes containing only the CYP of interest. The generation of mono-CYP containing mammalian cells and vesicles is difficult since endogenous CYPs are present in many cell types that contain the necessary co-factors. By obtaining translationally active lysates from a modified CHO-CPR cell line, it is now possible to generate mono CYPs in a cell-free protein synthesis process in a straightforward manner. As a proof of principle, the synthesis of active human CYPs from three different CYP450 gene families (CYP1A2, CYP2B6 and CYP3A4), which are of outstanding interest in industry and academia was demonstrated. Luciferase based activity assays confirm the activity of the produced CYPs and enable the individual adaptation of the synthesis process for efficient cell-free enzyme production. Furthermore, they allow for substrate and inhibitor screenings not only for wild-type CYPs but also for mutants and further CYP isoforms and variants. As an example, the turnover of selected CYP substrates by cell-free synthesized CYPs was demonstrated via an indirect luciferase assay-based screening setup.</abstract>
    <parentTitle language="eng">Scientific Reports</parentTitle>
    <identifier type="doi">10.1038/s41598-024-51781-6</identifier>
    <identifier type="issn">2045-2322</identifier>
    <enrichment key="opus_doi_flag">true</enrichment>
    <enrichment key="opus_doi_json">{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T00:20:15Z","timestamp":1705191615100},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T00:00:00Z","timestamp":1705104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004581","name":"Brandenburger Staatsministerium f\u00fcr Wissenschaft, Forschung und Kultur","doi-asserted-by":"publisher","award":["F241-03-FhG\/005\/001"]},{"name":"Fraunhofer-Institut f\u00fcr Zelltherapie und Immunologie IZI, Institutsteil Bioanalytik und Bioprozesse des Fraunhofer IZI-BB"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"&lt;jats:title&gt;Abstract&lt;\/jats:title&gt;&lt;jats:p&gt;Cytochromes P450 (CYPs) are a group of monooxygenases that can be found in almost all kinds of organisms. For CYPs to receive electrons from co-substrate NADPH, the activity of NADPH-Cytochrome-P450-oxidoreductase (CPR) is required as well. In humans, CYPs are an integral part of liver-based phase-1 biotransformation, which is essential for the metabolization of multiple xenobiotics and drugs. Consequently, CYPs are important players during drug development and therefore these enzymes are implemented in diverse screening applications. For these applications it is usually advantageous to use mono CYP microsomes containing only the CYP of interest. The generation of mono-CYP containing mammalian cells and vesicles is difficult since endogenous CYPs are present in many cell types that contain the necessary co-factors. By obtaining translationally active lysates from a modified CHO-CPR cell line, it is now possible to generate mono CYPs in a cell-free protein synthesis process in a straightforward manner. As a proof of principle, the synthesis of active human CYPs from three different CYP450 gene families (CYP1A2, CYP2B6 and CYP3A4), which are of outstanding interest in industry and academia was demonstrated. Luciferase based activity assays confirm the activity of the produced CYPs and enable the individual adaptation of the synthesis process for efficient cell-free enzyme production. Furthermore, they allow for substrate and inhibitor screenings not only for wild-type CYPs but also for mutants and further CYP isoforms and variants. As an example, the turnover of selected CYP substrates by cell-free synthesized CYPs was demonstrated via an indirect luciferase assay-based screening setup.&lt;\/jats:p&gt;","DOI":"10.1038\/s41598-024-51781-6","type":"journal-article","created":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T15:02:29Z","timestamp":1705158149000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synthesis of mono Cytochrome P450 in a modified CHO-CPR cell-free protein production platform"],"prefix":"10.1038","volume":"14","author":[{"given":"Jan Felix","family":"Knauer","sequence":"first","affiliation":[]},{"given":"Christian","family":"Schulz","sequence":"additional","affiliation":[]},{"given":"Anne","family":"Zemella","sequence":"additional","affiliation":[]},{"given":"Doreen A.","family":"W\u00fcstenhagen","sequence":"additional","affiliation":[]},{"given":"Ruben Magnus","family":"Walter","sequence":"additional","affiliation":[]},{"given":"Jan-Heiner","family":"K\u00fcpper","sequence":"additional","affiliation":[]},{"given":"Stefan","family":"Kubick","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,1,13]]},"reference":[{"issue":"6","key":"51781_CR1","doi-asserted-by":"publisher","first-page":"REVIEWS3003","DOI":"10.1186\/gb-2000-1-6-reviews3003","volume":"1","author":"D Werck-Reichhart","year":"2000","unstructured":"Werck-Reichhart, D. &amp; Feyereisen, R. Cytochromes P450: A success story. Genome Biol. 1(6), REVIEWS3003 (2000).","journal-title":"Genome Biol."},{"key":"51781_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-16009-2_1","volume":"851","author":"EG Hrycay","year":"2015","unstructured":"Hrycay, E. G. &amp; Bandiera, S. M. Monooxygenase, peroxidase and peroxygenase properties and reaction mechanisms of cytochrome P450 enzymes. Adv. Exp. Med. Biol. 851, 1\u201361 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"51781_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/jox11030007","volume":"11","author":"F Esteves","year":"2021","unstructured":"Esteves, F., Rueff, J. &amp; Kranendonk, M. The central role of cytochrome P450 in xenobiotic metabolism: A brief review on a fascinating enzyme family. J. Xenobiot. 11(3), 94\u2013114 (2021).","journal-title":"J. Xenobiot."},{"issue":"4","key":"51781_CR4","first-page":"421","volume":"13","author":"CC Ogu","year":"2000","unstructured":"Ogu, C. C. &amp; Maxa, J. L. Drug interactions due to cytochrome P450. Proceedings 13(4), 421\u20133 (2000).","journal-title":"Proceedings"},{"key":"51781_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jinorgbio.2018.03.002","volume":"183","author":"M \u0160rejber","year":"2018","unstructured":"\u0160rejber, M. et al. Membrane-attached mammalian cytochromes P450: An overview of the membrane\u2019s effects on structure, drug binding, and interactions with redox partners. J. Inorg. Biochem. 183, 117\u2013136 (2018).","journal-title":"J. Inorg. Biochem."},{"key":"51781_CR6","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/bs.apcsb.2020.06.005","volume":"122","author":"JD Finnigan","year":"2020","unstructured":"Finnigan, J. D., Young, C., Cook, D. J., Charnock, S. J. &amp; Black, G. W. Cytochromes P450 (P450s): A review of the class system with a focus on prokaryotic P450s. Adv. Protein Chem. Struct. Biol. 122, 289\u2013320 (2020).","journal-title":"Adv. Protein Chem. Struct. Biol."},{"issue":"5","key":"51781_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0006-2952(01)00843-7","volume":"63","author":"K Kobayashi","year":"2002","unstructured":"Kobayashi, K., Urashima, K., Shimada, N. &amp; Chiba, K. Substrate specificity for rat cytochrome P450 (CYP) isoforms: Screening with cDNA-expressed systems of the rat. Biochem. Pharmacol. 63(5), 889\u2013896 (2002).","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"51781_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1021\/tx100020p","volume":"23","author":"AD Patterson","year":"2010","unstructured":"Patterson, A. D., Gonzalez, F. J. &amp; Idle, J. R. Xenobiotic metabolism \u2013 a view through the metabolometer. Chem. Res. Toxicol. 23(5), 851\u2013860 (2010).","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"51781_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1389450118666170125144557","volume":"19","author":"P Manikandan","year":"2018","unstructured":"Manikandan, P. &amp; Nagini, S. Cytochrome P450 Structure, Function and Clinical Significance: A Review. Curr. Drug Targets 19(1), 38\u201354 (2018).","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"51781_CR10","first-page":"263","volume":"4","author":"AM McDonnell","year":"2013","unstructured":"McDonnell, A. M. &amp; Dang, C. H. Basic review of the cytochrome p450 system. J. Adv. Pract. Oncol. 4(4), 263\u2013268 (2013).","journal-title":"J. Adv. Pract. Oncol."},{"key":"51781_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fgene.2013.00012","volume":"4","author":"K Klein","year":"2013","unstructured":"Klein, K. &amp; Zanger, U. M. Pharmacogenomics of cytochrome P450 3A4: Recent progress toward the \u201cmissing heritability\u201d problem. Front. Genet. 4, 12 (2013).","journal-title":"Front. Genet."},{"key":"51781_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3389\/fgene.2013.00024","volume":"4","author":"UM Zanger","year":"2013","unstructured":"Zanger, U. M. &amp; Klein, K. Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): Advances on polymorphisms, mechanisms, and clinical relevance. Front. Genet. 4, 24 (2013).","journal-title":"Front. Genet."},{"issue":"6","key":"51781_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00216-008-2291-6","volume":"392","author":"UM Zanger","year":"2008","unstructured":"Zanger, U. M., Turpeinen, M., Klein, K. &amp; Schwab, M. Functional pharmacogenetics\/genomics of human cytochromes P450 involved in drug biotransformation. Anal. Bioanal. Chem. 392(6), 1093\u20131108 (2008).","journal-title":"Anal. Bioanal. Chem."},{"key":"51781_CR14","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.2174\/092986712801323180","volume":"19","author":"S Kumar","year":"2012","unstructured":"Kumar, S., Sharma, R. &amp; Roychowdhury, A. Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: A medicinal chemistry perspective. Curr. Med. Chem. 19, 3605\u20133621 (2012).","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"51781_CR15","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-pharmtox-010510-100514","volume":"51","author":"JS Walsh","year":"2011","unstructured":"Walsh, J. S. &amp; Miwa, G. T. Bioactivation of drugs: Risk and Drug design. Annu. Rev. Pharmacol. 51(1), 145\u201367 (2011).","journal-title":"Annu. Rev. Pharmacol."},{"issue":"2","key":"51781_CR16","doi-asserted-by":"publisher","first-page":"20171290","DOI":"10.1042\/BSR20171290","volume":"38","author":"J Hausjell","year":"2018","unstructured":"Hausjell, J., Halbwirth, H. &amp; Spadiut, O. Recombinant production of eukaryotic cytochrome P450s in microbial cell factories. Biosci. Rep. 38(2), 20171290 (2018).","journal-title":"Biosci. Rep."},{"issue":"1","key":"51781_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/dmd.112.048991","volume":"41","author":"DS Riddick","year":"2013","unstructured":"Riddick, D. S. et al. NADPH-cytochrome P450 oxidoreductase: Roles in physiology, pharmacology, and toxicology. Drug Metab. Dispos. 41(1), 12\u201323 (2013).","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"51781_CR18","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10930-011-9365-6","volume":"30","author":"Y Pan","year":"2011","unstructured":"Pan, Y. et al. Heterologous expression of human cytochromes P450 2D6 and CYP3A4 in Escherichia coli and their functional characterization. Protein. J. 30(8), 581\u2013591 (2011).","journal-title":"Protein. J."},{"issue":"1","key":"51781_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.pep.2007.06.007","volume":"56","author":"T Hamann","year":"2007","unstructured":"Hamann, T. &amp; M\u00f8ller, B. L. Improved cloning and expression of cytochrome P450s and cytochrome P450 reductase in yeast. Protein Expr. Purif. 56(1), 121\u2013127 (2007).","journal-title":"Protein Expr. Purif."},{"issue":"2","key":"51781_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1006\/abbi.1997.0405","volume":"348","author":"S Ding","year":"1997","unstructured":"Ding, S., Yao, D., Burchell, B., Wolf, C. R. &amp; Friedberg, T. High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation. Arch. Biochem. Biophys. 348(2), 403\u2013410 (1997).","journal-title":"Arch. Biochem. Biophys."},{"issue":"Pt 2","key":"51781_CR21","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1042\/bj3560613","volume":"356","author":"S Ding","year":"2001","unstructured":"Ding, S. et al. Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways. Biochem. J. 356(Pt 2), 613\u2013619 (2001).","journal-title":"Biochem. J."},{"issue":"2","key":"51781_CR22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.bbrc.2013.07.057","volume":"438","author":"H Ichinose","year":"2013","unstructured":"Ichinose, H. &amp; Wariishi, H. High-level heterologous expression of fungal cytochrome P450s in Escherichia coli. Biochem. Biophys. Res. Commun. 438(2), 289\u2013294 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7446","key":"51781_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature12051","volume":"496","author":"CJ Paddon","year":"2013","unstructured":"Paddon, C. J. et al. High-level semi-synthetic production of the potent antimalarial artemisinin. Nature 496(7446), 528\u2013532 (2013).","journal-title":"Nature"},{"issue":"2","key":"51781_CR24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nbt775","volume":"21","author":"FM Szczebara","year":"2003","unstructured":"Szczebara, F. M. et al. Total biosynthesis of hydrocortisone from a simple carbon source in yeast. Nat. Biotechnol. 21(2), 143\u2013149 (2003).","journal-title":"Nat. Biotechnol."},{"issue":"17","key":"51781_CR25","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.3390\/cells12172140","volume":"12","author":"C Schulz","year":"2023","unstructured":"Schulz, C., Herzog, N., Kubick, S., Jung, F. &amp; K\u00fcpper, J.-H. Stable Chinese hamster ovary suspension cell lines harboring recombinant human cytochrome P450 oxidoreductase and human cytochrome P450 monooxygenases as platform for in vitro biotransformation studies. Cells 12(17), 2140 (2023).","journal-title":"Cells"},{"issue":"1","key":"51781_CR26","doi-asserted-by":"publisher","first-page":"14193","DOI":"10.1038\/s41598-020-71035-5","volume":"10","author":"M Kumondai","year":"2020","unstructured":"Kumondai, M. et al. Heterologous expression of high-activity cytochrome P450 in mammalian cells. Sci. Rep. 10(1), 14193 (2020).","journal-title":"Sci. Rep."},{"issue":"9","key":"51781_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163670","volume":"11","author":"L Thoring","year":"2016","unstructured":"Thoring, L. et al. Cell-free systems based on CHO cell lysates: Optimization strategies, synthesis of \u201cdifficult-to-express\u201d proteins and future perspectives. PLoS ONE 11(9), e0163670 (2016).","journal-title":"PLoS ONE"},{"issue":"4","key":"51781_CR28","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/bit.24785","volume":"110","author":"Y-C Kwon","year":"2013","unstructured":"Kwon, Y.-C. et al. Integrating cell-free biosyntheses of heme prosthetic group and apoenzyme for the synthesis of functional P450 monooxygenase. Biotechnol. Bioeng. 110(4), 1193\u20131200 (2013).","journal-title":"Biotechnol. Bioeng."},{"key":"51781_CR29","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s40259-020-00417-y","volume":"34","author":"SK Dondapati","year":"2020","unstructured":"Dondapati, S. K., Stech, M., Zemella, A. &amp; Kubick, S. Cell-free protein synthesis: A promising option for future drug development. BioDrugs 34, 327\u2013348 (2020).","journal-title":"BioDrugs"},{"issue":"12","key":"51781_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082234","volume":"8","author":"AK Br\u00f6del","year":"2013","unstructured":"Br\u00f6del, A. K. et al. IRES-mediated translation of membrane proteins and glycoproteins in eukaryotic cell-free systems. PLoS ONE 8(12), e82234 (2013).","journal-title":"PLoS ONE"},{"issue":"1","key":"51781_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/bit.25013","volume":"111","author":"AK Br\u00f6del","year":"2014","unstructured":"Br\u00f6del, A. K., Sonnabend, A. &amp; Kubick, S. Cell-free protein expression based on extracts from CHO cells. Biotechnol. Bioeng. 111(1), 25\u201336 (2014).","journal-title":"Biotechnol. Bioeng."},{"key":"51781_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.enzmictec.2022.110110","volume":"161","author":"JF Knauer","year":"2022","unstructured":"Knauer, J. F. et al. Cell-free production of the bifunctional glycoside hydrolase GH78 from Xylaria polymorpha. Enzyme Microb. Technol. 161, 110110 (2022).","journal-title":"Enzyme Microb. Technol."},{"issue":"2","key":"51781_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jbiotec.2012.08.020","volume":"164","author":"M Stech","year":"2012","unstructured":"Stech, M. et al. Production of functional antibody fragments in a vesicle-based eukaryotic cell-free translation system. J. Biotechnol. 164(2), 220\u2013231 (2012).","journal-title":"J. Biotechnol."},{"issue":"2","key":"51781_CR34","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1074\/jbc.275.2.1471","volume":"275","author":"MJ Paine","year":"2000","unstructured":"Paine, M. J. et al. Cloning and characterization of a novel human dual flavin reductase. J. Biol. Chem. 275(2), 1471\u20131478 (2000).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"51781_CR35","doi-asserted-by":"publisher","first-page":"11710","DOI":"10.1038\/s41598-017-12188-8","volume":"7","author":"L Thoring","year":"2017","unstructured":"Thoring, L., Dondapati, S. K., Stech, M., W\u00fcstenhagen, D. A. &amp; Kubick, S. High-yield production of \u201cdifficult-to-express\u201d proteins in a continuous exchange cell-free system based on CHO cell lysates. Sci. Rep. 7(1), 11710 (2017).","journal-title":"Sci. Rep."},{"key":"51781_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ymeth.2018.04.014","volume":"147","author":"M-K Kang","year":"2018","unstructured":"Kang, M.-K. &amp; Tullman-Ercek, D. Engineering expression and function of membrane proteins. Methods 147, 66\u201372 (2018).","journal-title":"Methods"},{"issue":"6","key":"51781_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1139\/bcb-2015-0143","volume":"94","author":"A Pandey","year":"2016","unstructured":"Pandey, A., Shin, K., Patterson, R. E., Liu, X.-Q. &amp; Rainey, J. K. Current strategies for protein production and purification enabling membrane protein structural biology. Biochem. Cell Biol. Biochim. Biol. Cell. 94(6), 507\u201327 (2016).","journal-title":"Biochem. Cell Biol. Biochim. Biol. Cell."},{"issue":"12","key":"51781_CR38","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrd.2017.178","volume":"16","author":"AS Hauser","year":"2017","unstructured":"Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schi\u00f6th, H. B. &amp; Gloriam, D. E. Trends in GPCR drug discovery: New agents, targets and indications. Nat. Rev. Drug Discov. 16(12), 829\u2013842 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"issue":"17","key":"51781_CR39","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1016\/j.febslet.2014.06.007","volume":"588","author":"R Sachse","year":"2014","unstructured":"Sachse, R., Dondapati, S. K., Fenz, S. F., Schmidt, T. &amp; Kubick, S. Membrane protein synthesis in cell-free systems: From bio-mimetic systems to bio-membranes. FEBS Lett. 588(17), 2774\u20132781 (2014).","journal-title":"FEBS Lett."},{"issue":"4","key":"51781_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3390\/toxins14040233","volume":"14","author":"F Ramm","year":"2022","unstructured":"Ramm, F. et al. Cell-free systems enable the production of ab5 toxins for diagnostic applications. Toxins 14(4), 233 (2022).","journal-title":"Toxins"},{"key":"51781_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fbioe.2019.00248","volume":"7","author":"K Khambhati","year":"2019","unstructured":"Khambhati, K. et al. Exploring the potential of cell-free protein synthesis for extending the abilities of biological systems. Front. Bioeng. Biotechnol. 7, 248 (2019).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"5","key":"51781_CR42","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.bbamem.2013.12.009","volume":"1838","author":"SF Fenz","year":"2014","unstructured":"Fenz, S. F., Sachse, R., Schmidt, T. &amp; Kubick, S. Cell-free synthesis of membrane proteins: Tailored cell models out of microsomes. Biochim. Biophys. Acta 1838(5), 1382\u20131388 (2014).","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"51781_CR43","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1007\/s12010-013-0303-2","volume":"170","author":"I Neunzig","year":"2013","unstructured":"Neunzig, I. et al. Coexpression of CPR from various origins enhances biotransformation activity of human CYPs in S. pombe. Appl. Biochem. Biotechnol. 170(7), 1751\u201366 (2013).","journal-title":"Appl. Biochem. Biotechnol."},{"key":"51781_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s13028-014-0069-8","volume":"56","author":"E Tyd\u00e9n","year":"2014","unstructured":"Tyd\u00e9n, E., Tj\u00e4lve, H. &amp; Larsson, P. Gene and protein expression and cellular localisation of cytochrome P450 enzymes of the 1A, 2A, 2C, 2D and 2E subfamilies in equine intestine and liver. Acta Vet. Scand. 56, 69 (2014).","journal-title":"Acta Vet. Scand."},{"issue":"1","key":"51781_CR45","doi-asserted-by":"publisher","first-page":"ysy012","DOI":"10.1093\/synbio\/ysy012","volume":"3","author":"LE Contreras-Llano","year":"2018","unstructured":"Contreras-Llano, L. E. &amp; Tan, C. High-throughput screening of biomolecules using cell-free gene expression systems. Synth. Biol. 3(1), ysy012 (2018).","journal-title":"Synth. Biol."},{"issue":"5","key":"51781_CR46","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4062\/biomolther.2015.041","volume":"23","author":"Y-H Kim","year":"2015","unstructured":"Kim, Y.-H. et al. Measurement of human cytochrome P450 enzyme induction based on mesalazine and mosapride citrate treatments using a luminescent assay. Biomol. Ther. 23(5), 486\u2013492 (2015).","journal-title":"Biomol. Ther."},{"issue":"5","key":"51781_CR47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/1087057108317480","volume":"13","author":"L Bell","year":"2008","unstructured":"Bell, L. et al. Evaluation of fluorescence- and mass spectrometry-based CYP inhibition assays for use in drug discovery. J. Biomol. Screen. 13(5), 343\u2013353 (2008).","journal-title":"J. Biomol. Screen."},{"issue":"3","key":"51781_CR48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0092-8674(00)81115-0","volume":"85","author":"H Do","year":"1996","unstructured":"Do, H., Falcone, D., Lin, J., Andrews, D. W. &amp; Johnson, A. E. The cotranslational integration of membrane proteins into the phospholipid bilayer is a multistep process. Cell 85(3), 369\u2013378 (1996).","journal-title":"Cell"},{"key":"51781_CR49","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-cellbio-100616-060439","volume":"33","author":"TA Rapoport","year":"2017","unstructured":"Rapoport, T. A., Li, L. &amp; Park, E. Structural and mechanistic insights into protein translocation. Annu. Rev. Cell Dev. Biol. 33, 369\u2013390 (2017).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"5","key":"51781_CR50","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/pro.3603","volume":"28","author":"HC Huff","year":"2019","unstructured":"Huff, H. C., Maroutsos, D. &amp; Das, A. Lipid composition and macromolecular crowding effects on CYP2J2-mediated drug metabolism in nanodiscs. Protein Sci. 28(5), 928\u2013940 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"51781_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/03602532.2010.515222","volume":"43","author":"MA Correia","year":"2011","unstructured":"Correia, M. A., Sinclair, P. R. &amp; de Matteis, F. Cytochrome P450 regulation: The interplay between its heme and apoprotein moieties in synthesis, assembly, repair, and disposal. Drug Metab. Rev. 43(1), 1\u201326 (2011).","journal-title":"Drug Metab. Rev."},{"issue":"3","key":"51781_CR52","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1182\/blood.V100.3.879","volume":"100","author":"V Jeney","year":"2002","unstructured":"Jeney, V. et al. Pro-oxidant and cytotoxic effects of circulating heme. Blood 100(3), 879\u2013887 (2002).","journal-title":"Blood"},{"issue":"4","key":"51781_CR53","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0002-9629(15)40628-7","volume":"318","author":"P Ponka","year":"1999","unstructured":"Ponka, P. Cell biology of heme. Am. J. Med. Sci. 318(4), 241\u2013256 (1999).","journal-title":"Am. J. Med. Sci."},{"key":"51781_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.964396","volume":"10","author":"RM Walter","year":"2022","unstructured":"Walter, R. M., Zemella, A., Schramm, M., Kiebist, J. &amp; Kubick, S. Vesicle-based cell-free synthesis of short and long unspecific peroxygenases. Front. Bioeng. Biotechnol. 10, 964396 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"4","key":"51781_CR55","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/elsc.201400036","volume":"14","author":"M Stech","year":"2014","unstructured":"Stech, M., Hust, M., Schulze, C., D\u00fcbel, S. &amp; Kubick, S. Cell-free eukaryotic systems for the production, engineering, and modification of scFv antibody fragments. Eng. Life Sci. 14(4), 387\u2013398 (2014).","journal-title":"Eng. Life Sci."},{"key":"51781_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.896763","volume":"10","author":"L Haueis","year":"2022","unstructured":"Haueis, L., Stech, M. &amp; Kubick, S. A Cell-free expression pipeline for the generation and functional characterization of nanobodies. Front. Bioeng. Biotechnol. 10, 896763 (2022).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"51781_CR57","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.reprotox.2021.07.012","volume":"104","author":"A Sadowska","year":"2021","unstructured":"Sadowska, A. et al. Transcriptional profiling of Chinese hamster ovary (CHO) cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Reprod. Toxicol. 104, 143\u201354 (2021).","journal-title":"Reprod. Toxicol."},{"key":"51781_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/0471140856.tx0413s20","volume":"20","author":"KA Usmani","year":"2004","unstructured":"Usmani, K. A. &amp; Tang, J. Human cytochrome P450: Metabolism of testosterone by CYP3A4 and inhibition by ketoconazole. Curr. Protoc. Toxicol. 20, 4\u201313 (2004).","journal-title":"Curr. Protoc. Toxicol."},{"issue":"3","key":"51781_CR59","first-page":"825","volume":"299","author":"D Dai","year":"2001","unstructured":"Dai, D. et al. Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J. Pharmacol. Exp. Ther. 299(3), 825\u2013831 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"11","key":"51781_CR60","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1177\/0091270004269142","volume":"44","author":"N Hariparsad","year":"2004","unstructured":"Hariparsad, N. et al. Induction of CYP3A4 by efavirenz in primary human hepatocytes: Comparison with rifampin and phenobarbital. J. Clin. Pharmacol. 44(11), 1273\u20131281 (2004).","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"51781_CR61","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/acs.molpharmaceut.8b01043","volume":"16","author":"K Xiao","year":"2019","unstructured":"Xiao, K. et al. CYP3A4\/5 activity probed with testosterone and midazolam: Correlation between two substrates at the microsomal and enzyme levels. Mol. Pharm. 16(1), 382\u2013392 (2019).","journal-title":"Mol. Pharm."},{"issue":"7","key":"51781_CR62","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2174\/138920009789895552","volume":"10","author":"S-F Zhou","year":"2009","unstructured":"Zhou, S.-F. et al. Insights into the structure, function, and regulation of human cytochrome P450 1A2. Curr. Drug Metab. 10(7), 713\u2013729 (2009).","journal-title":"Curr. Drug Metab."},{"issue":"6","key":"51781_CR63","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1365-2125.2012.04288.x","volume":"74","author":"C Sukasem","year":"2012","unstructured":"Sukasem, C. et al. Pharmacogenetic markers of CYP2B6 associated with efavirenz plasma concentrations in HIV-1 infected Thai adults. Br. J. Clin. Pharmacol. 74(6), 1005\u20131012 (2012).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"51781_CR64","first-page":"1253","volume":"286","author":"S Ekins","year":"1998","unstructured":"Ekins, S. et al. Further characterization of the expression in liver and catalytic activity of CYP2B6. J. Pharmacol. Exp. Ther. 286(3), 1253\u20131259 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"5","key":"51781_CR65","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1006\/bbrc.2001.4524","volume":"281","author":"N Ariyoshi","year":"2001","unstructured":"Ariyoshi, N., Miyazaki, M., Toide, K., Sawamura, Y. &amp; Kamataki, T. A single nucleotide polymorphism of CYP2b6 found in Japanese enhances catalytic activity by autoactivation. Biochem. Biophys. Res. Commun. 281(5), 1256\u20131260 (2001).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51781-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51781-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51781-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T16:02:05Z","timestamp":1705161725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51781-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,13]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51781"],"URL":"http:\/\/dx.doi.org\/10.1038\/s41598-024-51781-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":["Multidisciplinary"],"published":{"date-parts":[[2024,1,13]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1271"}}</enrichment>
    <enrichment key="opus_crossrefDocumentType">journal-article</enrichment>
    <enrichment key="opus_crossrefLicence">https://creativecommons.org/licenses/by/4.0</enrichment>
    <enrichment key="opus_import_origin">crossref</enrichment>
    <enrichment key="opus_doiImportPopulated">SubjectUncontrolled_1,PersonAuthorFirstName_1,PersonAuthorLastName_1,PersonAuthorFirstName_2,PersonAuthorLastName_2,PersonAuthorFirstName_3,PersonAuthorLastName_3,PersonAuthorFirstName_4,PersonAuthorLastName_4,PersonAuthorFirstName_5,PersonAuthorLastName_5,PersonAuthorFirstName_6,PersonAuthorLastName_6,PersonAuthorFirstName_7,PersonAuthorLastName_7,PublisherName,TitleMain_1,Language,TitleAbstract_1,TitleParent_1,ArticleNumber,Issue,Volume,PublishedYear,IdentifierIssn,Enrichmentopus_crossrefLicence</enrichment>
    <enrichment key="BTU">an der BTU erstellt / created at BTU</enrichment>
    <enrichment key="Referiert">Beitrag ist referiert / Article peer-reviewed</enrichment>
    <enrichment key="Publikationsweg">Open Access</enrichment>
    <enrichment key="opus.source">doi-import</enrichment>
    <enrichment key="Artikelnummer">1271</enrichment>
    <enrichment key="opus.doi.autoCreate">false</enrichment>
    <enrichment key="opus.urn.autoCreate">false</enrichment>
    <enrichment key="Fprofil">2 Gesundheit und Lifes Sciences / Health and Life Sciences</enrichment>
    <enrichment key="Fprofil">3 Globaler Wandel und Transformationsprozesse / Global Change and Transformation Processes</enrichment>
    <author>
      <firstName>Jan Felix</firstName>
      <lastName>Knauer</lastName>
    </author>
    <submitter>
      <firstName>Christian</firstName>
      <lastName>Schulz</lastName>
    </submitter>
    <author>
      <firstName>Christian</firstName>
      <lastName>Schulz</lastName>
    </author>
    <author>
      <firstName>Anne</firstName>
      <lastName>Zemella</lastName>
    </author>
    <author>
      <firstName>Doreen A.</firstName>
      <lastName>Wüstenhagen</lastName>
    </author>
    <author>
      <firstName>Ruben Magnus</firstName>
      <lastName>Walter</lastName>
    </author>
    <author>
      <firstName>Jan-Heiner</firstName>
      <lastName>Küpper</lastName>
    </author>
    <author>
      <firstName>Stefan</firstName>
      <lastName>Kubick</lastName>
    </author>
    <subject>
      <language>eng</language>
      <type>uncontrolled</type>
      <value>Multidisciplinary</value>
    </subject>
    <collection role="institutes" number="2110">FG Molekulare Zellbiologie</collection>
  </doc>
</export-example>
